Mental Health Association of Portland

Oregon's independent and impartial mental health advocate

Disrespectful McDonald’s ad pulled after consumer complaints

Posted by Jenny on 27th April 2013

I'm NOT loving it - McDonalds

McDonald’s is not lovin’ it.

Following consumer complaints, a regional ad for its Big Mac that parodies mental illness — featuring a familiar photo of a woman who appears to be crying with her head in her hand — has been yanked by the fast-food giant from Massachusetts Bay Transportation Authority subway trains. The headline in the ad states: “You’re not alone.” But the small print underneath says, “Millions of people love the Big Mac.”

Worst of all: The ad includes a toll-free phone number that connects consumers to McDonald’s customer satisfaction line. A recording asks consumers if they want to share an “experience” that they had at a McDonald’s restaurant.

“The worst possible situation is if someone in an emotional crisis were to see that image and call that number,” says Bob Carolla, spokesman for the National Alliance on Mental Illness. “It would be a cruel mistake.”

Image from the now discontinued McDonald's ad

Image from the now discontinued McDonald’s ad

Mistake, indeed. The public relations blunder comes at a time other big-name brands have made similar PR miscues. A recent Ford ad in India depicted sexy women tied up in the back of a Ford Figo. Nabisco has received complaints about a Wheat Thins spot featuring a puppet who is so obsessed with the savory crackers that it must be tied in a straitjacket by mental health workers. And now this McDonald’s ad, which appeared on subway trains in the Boston area.

One PR expert is baffled by the McDonald’s ad. “This is honest-to-goodness God-awful,” says Katharine Delahaye Paine, chief marketing officer at News Group, a social-media monitoring company. “You don’t make fun of ads for non-profits.”

McDonald’s has apologized, blaming its regional agency for posting an ad that it did not approve. “We can confirm this ad was not approved by McDonald’s,” the statement says. “As soon as we learned about it, we asked that it be taken down immediately.”

Know Me As a Person - girlPam Hamlin, president of the Boston office of the ad agency Arnold Worldwide — which remains McDonald’s regional agency — also apologized, in a statement. “Arnold apologizes for its mistake to McDonald’s and to anyone who was offended by the ad,” she says. “We’ve addressed the issue and have improved our approval process.”

But the damage has been done.

Paine, the PR specialist, says McDonald’s needs to be more transparent and not just finger-point at its ad agency. “In an ideal world, they would be more transparent about the approval process” that was not obeyed by the agency, she says.

Carolla, the NAMI spokesman, says that advertising agencies tend to be the worst offenders in perpetuating mental illness stereotypes. “Either they don’t think,” he says, “or they just don’t care.”

Tags: , , , , , , ,
Posted in Uncategorized | No Comments »

Portland Police Bureau picks about 50 officers for specialized unit handling mental health crisis calls

Posted by Jenny on 9th April 2013

Chief Mike Reese (center)

Chief Mike Reese (center)

By Maxine Bernstein, The Oregonian, April 9, 2013

Portland police have selected about 50 officers who volunteered to be part of a new specialized unit to respond to mental health crisis calls.

The new unit is one of the initiatives that federal justice investigators last year urged the bureau to adopt to improve police encounters with people suffering from mental illness.

The U.S. Department of Justice found last year that Portland police engaged in a pattern of excessive force against people with mental illness.

The Portland officers assigned to the bureau’s Enhanced Crisis Intervention Team will remain on patrol but become the go-to responders on mental health crisis calls.

While all Portland patrol officers have received 40 hours of crisis intervention training, this group will receive an additional 40 hours over four days next month that’s based on input from mental health agencies and consumers.

The training will include classroom instruction, role-playing, tours of mental health facilities and a panel discussion with people living with mental illness and their family members.

Central Precinct Officer Amy Bruner-Denhart, who joined the bureau 8-1/2 yrs ago, will serve as the team coordinator.

“We have high hopes that when someone is a volunteer, they’ll be perhaps more familiar and more able to react in a highly supportive manner,” said Terri Walker, board president of the Multnomah County chapter of the National Alliance on Mental Illness.

Police have also created the Behavioral Health Coordination Team, with  police meeting twice a month with representatives of mental health care agencies. Together, they identify the city’s most vulnerable citizens who have been the subject of repeated police calls or are considered a heightened danger to refer them to appropriate treatment.

“Our hope is we can plug the right person with the right agency,” Central Precinct Cmdr. Bob Day said Tuesday.

Lt. Cliff Bacigalupi said the Behavioral Health Coordination Team is modeled after the bureau’s existing Service Coordination Team, which works to connect repeat low-level offenders with alcohol treatment and housing.

The Behavioral Health Coordination Team meets every other Friday, drawing representatives from agencies such as Cascadia Behavioral Healthcare, the U.S. Department of Veterans Affairs, Transition Projects and Multnomah County’s Mental Health and Addiction Services, along with a new county prosecutor assigned to mental health cases and county jail medical staff.

Laura Maurer, the county’s deputy district attorney assigned since September to work on mental health matters, said she attends the meetings to help police or mental health care providers navigate legal matters that might arise. She also works to educate officers and others on what’s needed for civil commitment hearings.

Last month, the U.S. Department of Justice urged the bureau to return to a specialized group of officers who have the desire, crisis intervention training and skills to work with people suffering from mental illness. The federal review found Portland’s crisis training sorely lacked key components: “live exposure” to mental health consumers and family members, role-playing scenarios and community collaboration.

Portland police had adopted the Memphis model in 1995, creating a specialized team of volunteer officers to respond to crisis calls after the 1992 Portland police shooting of Nathan Thomas, a 12-year-old held hostage by a mentally ill man with a knife. Portland police started it with 60 officers who volunteered for the 40-hour training and, within 18 months, grew to 185 officers.

But the bureau veered away from the voluntary training and required that all officers be trained in 2007. The switch came after the controversial 2006 death in police custody of James P. Chasse Jr., who suffered from paranoid schizophrenia.

Shannon Pullen, interim executive director of the National Alliance on Mental Illness’ Multnomah chapter, is co-chairing a new advisory committee for the police bureau’s Behavioral Health Unit.  It has met twice this year and includes members of Central City Concern, Volunteers of America, Cascadia, Disability Rights Oregon and mental health consumers.

Pullen said she’s excited that police are engaging a diverse group of people who work in the mental health field. The advisory panel will sit in on next month’s enhanced crisis intervention training and is coordinating a panel to address the officers.

“It’s what the community has wanted,” Pullen said. “My mantra is engagement. We can only work better together and try to see the issue from each other’s point of view. And, hopefully, it’ll result in better outcomes.”

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,
Posted in Uncategorized | No Comments »

The limits of lithium, and the hunt for a better alternative

Posted by Jenny on 28th March 2013

By Bethany Halford, Chemical & Engineering News, March 25, 2013

Bipolar-DisorderWhen something goes wrong with the inner workings of the body, we call it a disease. When things go awry in the mind’s fine machinery, we call it madness. Risdon Slate knows all about that. It has been more than 25 years since the events that led to his diagnosis of bipolar disorder. But he has no trouble recalling them.

In 1986, he was a 26-year-old U.S. probation officer visiting Miami for training. At one point, he remembers sitting in his hotel bar and getting into an argument with a man whom he perceived was playing the role of his father. “I actually believed that I was on the set of ‘Miami Vice’ and that I was going to be in an episode of the TV show,” Slate says. The police got involved, and Slate told officers that he would not answer any questions unless they were posed to him by Sonny Crockett, the fictional undercover police officer and central character of “Miami Vice.”

The retelling is almost comical, but the consequences for Slate were anything but. As a result of his bipolar disorder, Slate lost his job as a U.S. probation officer. His wife left him. A few years later, after a doctor took him off medication, Slate experienced a second manic episode, which led to an arrest (which has since been expunged) and a brutal physical assault while he was in jail. A bipolar patient swings between bouts of mania—when a patient can feel irrationally euphoric—and depression.

For the past 20 years though, Slate has managed to keep his disorder in check thanks to the drug lithium. “Taking the medication has been the key,” says Slate, now a professor of criminology at Florida Southern College. “It is essentially saving my life.”

Like Slate, 9 million people in the U.S. struggle with the disease at some point in their lives, according to the National Institute of Mental Health. Although roughly a dozen drugs are approved to treat bipolar mania and prevent or delay the onset of manic or depressive episodes, in many ways, lithium stands alone. Psychiatrists often turn to lithium—usually given as the salt lithium carbonate—as a first-line drug for patients. Its ability to calm the highs of mania and lift the lows of depression has been known for more than 60 years. It’s the only medication that demonstrably reduces the risk of suicide in bipolar patients. And it’s inexpensive.

Bipolar treatmentsBut lithium is not a panacea. The drug’s therapeutic window is very narrow—that is, its toxic dose is only about two to three times higher than its therapeutic dose. Patients who take lithium also need to have the ion monitored in their blood to make sure it’s below toxic levels. And there are the side effects: tremors, frequent urination, thyroid problems, weight gain, and, in some cases, kidney failure.

In the hope of skirting lithium’s limitations, scientists are trying to figure out exactly how the drug works and, in particular, hunt down its targets. The idea is this: Because lithium is an ion, it hits several different cellular targets, which is why it has so many side effects. If scientists can figure out which of those targets are responsible for its mood-stabilizing properties, they might be able to hit them specifically, using a small molecule that doesn’t have lithium’s downsides.

“For some percentage of patients, lithium really does have a lot of the characteristics of an ideal treatment,” says psychiatrist Gary S. Sachs, founding director of the Bipolar Clinic & Research Program at Massachusetts General Hospital. “However, that is a relatively small percentage of patients.”

Other drugs approved to treat bipolar disorder were originally developed as anticonvulsants to treat epilepsy or as antipsychotics to treat schizophrenia. Thanks to their ability to level out certain moods, the drugs have been used to treat bipolar patients. It’s not clear how these drugs work either, and they often have more adverse side effects than lithium. All bipolar medications carry the U.S. Food & Drug Administration’s “black box” warning, Sachs points out, indicating they carry the risk of death. “Patients aren’t in a hurry to take those drugs,” he says.

Molecules“People find the side effects aversive, so they find ways to go off their medicine,” adds psychiatrist Kenneth Duckworth, medical director of the National Alliance on Mental Illness.

Scientists don’t really know what causes bipolar disorder, which was once known as manic depressive illness. It can strike at any age.

The disorder is unique among psychiatric illnesses, Duckworth points out, because people experience one phase of it, hypomania, positively. “People feel funnier, sexier, and more energetic,” he explains. They don’t want to take their medication, but they may be on their way to mania and psychosis.

Doctors split bipolar patients into two subgroups. Those with bipolar disorder type I, like Slate, have had at least one full-blown manic episode. Patients with bipolar disorder type II experience hypomania but not mania. Both type I and type II patients wrestle with depression, usually for far longer periods than they experience hypomania or mania.

“My depression feels like hell,” says Rebecca Gatlin, a 30-year-old nursing student who was diagnosed with bipolar disorder at age 19. “You have to push yourself to do every little thing,” Gatlin says. “You put so much effort into getting out of bed and brushing your teeth. Everything takes so much effort that you’re so exhausted and you walk around listless. You’re so exhausted from the littlest thing.

“You know that there are only two ways to get through it—to hang on until it lets up and things get better or the medicine kicks in, or you make a plan to end your life, and that’s not really a viable option,” Gatlin says. “You’re stuck holding on for life.”

“When you call depression mild, it’s sort of like saying you’ve had a mild heart attack,” Sachs says. The depressive phase of bipolar disorder can be extremely disabling, he says, and doctors don’t have many pharmaceutical options for treatment.

In 2007, Sachs and coworkers released the results of the Systematic Treatment Enhancement Program for Bipolar Disorder, or STEP-BD, the largest federally funded treatment trial ever conducted for bipolar disorder. They learned that antidepressants are no better at treating bipolar disorder than a placebo.

“So far, the track record of the so-called standard antidepressants has been terrible in terms of their ability to treat bipolar depression,” Sachs says. “None of them have proven to be effective, even though they are the most commonly prescribed drugs. So there is an area of great need to find novel compounds that would either treat or prevent depression in bipolar people.”

Lithium has a reputation for being moderately effective at treating or preventing bipolar depression. Scientists know that lithium displaces magnesium ions and inhibits at least 10 cellular targets. They have been able to narrow that range on the basis of what lithium inhibits at therapeutically relevant concentrations, roughly 0.6 to 1 mM.

One putative lithium target researchers have been pursuing for decades is inositol monophosphatase, or IMPase. The enzyme is part of the phosphatidylinositol signaling pathway. It strips the phosphate off of inositol phosphate to produce inositol, a key substance in the biosynthesis of compounds that trigger cellular responses.

There is some evidence that in bipolar patients the phosphatidylinositol signaling pathway becomes hyperactive. Inhibiting IMPase halts the pathway and depletes inositol. Adding credence to this theory, researchers have fingered inositol depletion in the mechanisms of two other bipolar medications—carbamazepine (Tegretol) and divalproex (Depakote), also called valproic acid.

“How can we really be sure that lithium works to treat bipolar disorder by inhibiting IMPase?” asks John R. Atack, director of translational drug discovery at En­gland’s University of Sussex. “You make a good inhibitor of IMPase and see if it works in treating people with bipolar disorder.”

In the 1990s, Atack was part of a team at Merck & Co. trying to do just that. Reckoning they couldn’t do any medicinal chemistry on an elemental ion, because they couldn’t adjust its structure, Atack and coworkers developed IMPase inhibitors based on the enzyme’s substrate—inositol monophosphate.

Eventually they came up with an antagonist capable of inhibiting the enzyme at nanomolar concentrations. Polar phosphonate groups proved to be crucial to the compound’s ability to bind in IMPase’s active site, but the phosphonates kept the molecule from being bioavailable. “To get enzyme inhibition you need polar molecules,” Atack explains, “but those polar molecules don’t stand a very good chance of getting into the brain at high levels.”

The group tried to circumvent the problem by turning the molecule into an ester prodrug that could cross the membrane of the cell. It didn’t help. “If you inject that compound into an animal, it just sits there in a greasy lump,” Atack says.

Finally, the team used X-ray crystallography to study IMPase’s active site. “It confirmed what we already knew. The active site is very polar and therefore you need polar molecules to bind in it,” he says. Furthermore, the enzyme has no convenient greasy pockets where something less polar might do the job. “At that point, we didn’t really know where to go next,” Atack says, and the project was shelved. Talking about his work with IMPase is “like talking about an old girlfriend,” he adds. “She took a big chunk of my life, and I still have affection for her.

“It’s an unanswered question whether IMPase would be a good therapeutic target or not,” Atack adds. “Merck put a heroic effort into this and got nothing out of it. Perhaps it is an attractive but intractable target.”

Since then, scientists have largely been silent about any efforts to come up with IMPase inhibitors. Late last year, however, a team led by Grant C. Churchill and Sridhar R. Vasudevan, of the University of Oxford, in England, reported that the compound ebselen can inhibit IMPase (Nat. Commun., DOI: 10.1038/ncomms2320).

Ebselen, an anti-inflammatory antioxidant, was originally developed by Daiichi Sankyo, in Japan, to treat patients who had suffered a stroke. But the compound was never marketed and has since come off patent. It’s also part of the National Institutes of Health Clinical Collection—several hundred small molecules that have, to some extent, gone through the gamut of human clinical trials and have been found to be safe, but never reached final FDA approval.

In addition to inhibiting IMPase in vitro, the Oxford researchers found ebselen has lithium-like effects in a mouse model of mania. The compound calms mice that have taken amphetamine. Subsequent administration of inositol reverses the behavior, Churchill says, which is a clue that ebselen affects inositol recycling.

Since the report came out, Churchill says, a few psychiatrists have started to apply for funds to study ebselen’s effects in bipolar patients. At Oxford, doctors are giving the compound to a small group of healthy adults to see how it affects inositol processing in the brain. Ebselen has gone from identification as a potential bipolar treatment to human trials in about two years, Churchill points out. “That is incredibly fast for any drug discovery effort.”

Some, however, are skeptical that IMPase is a viable target for making lithium mimics. The target was discredited years ago, says Edward M. Scolnick, who served as president of Merck & Co. from 1982 through 2002. Rather, he believes the key to finding better treatments for bipolar disorder lies in unraveling the disease’s genetics. Currently chief scientist at Broad Institute’s Stanley Center for Psychiatric Research, Scolnick is part of an effort trying to do just that.

“The single largest risk factor for a person becoming bipolar is genetic,” Scolnick explains. Scientists can’t study the biochemistry of the living human brain, he points out, and imaging methods lack the sensitivity to pick up molecular causes. So, Scolnick says, the only way to get a handle of the underlying pathophysiology and biochemistry of bipolar disorder is to find the genes related to illness and see what biochemical pathways they point to. “Unless one understands the underlying biochemistry of the human disease—not some animal model that has no clear relationship to the human disease—one will never be able to make important new therapeutics,” he says.

Scolnick is not the only one to voice concerns about animal models for bipolar disorder. Psychiatrist Carlos A. Zarate, chief of the National Institute of Mental Health’s (NIMH) Section on the Neurobiology & Treatment of Mood Disorders, also notes that these models of the disease leave something to be desired.

Typically, the complex mental state of mania is modeled by giving mice amphetamines. Scientists test antidepressants on animals by forcing rodents to swim or suspending them by their tails. The length of time the creature swims or struggles is supposed to be indicative of the antidepressant’s efficacy.

Correlating animal tests that take only a few minutes with a patient who’s suffered from a disease for decades is problematic, Zarate says. With such imprecise animal models and uncertainty about a disease’s pathophysiology, he adds, it’s no wonder that companies are hesitant to get into psychiatric diseases.

Until the genetics become clear enough to show what pathways to pursue, Scolnick says, he and his colleagues at the Stanley Center are working on developing inhibitors of another putative therapeutic target of lithium: glycogen synthase kinase-3, or GSK-3.

GSK-3 appends phosphate groups to serine and threonine amino acid residues. It functions in many pathways and has been implicated in diseases such as Alzheimer’s, type 2 diabetes, and cancer. “What it does in the human brain is very hard to tell,” says Peter S. Klein, the University of Pennsylvania professor of medicine who discovered that lithium inhibits GSK-3. One possibility is that lithium’s inhibition of GSK-3 turns on the Wnt signaling pathway, which stimulates the generation of neurons.

Inhibitors of GSK-3 are currently in clinical trials to treat progressive supranuclear palsy and certain cancers. But there are few reports of GSK-3 inhibitors being developed for bipolar disorder.

In 2007, researchers led by Alan P. Kozikowski, a chemistry professor at the University of Illinois, Chicago, reported that 3-benzofuranyl-4-indolylmaleimides are potent and selective inhibitors of GSK-3 (J. Am. Chem. Soc., DOI:10.1021/ja068969w). The most promising of the compounds Kozikowski’s team made calmed hyperactive behavior in mice that took amphetamine—the same model system of mania the ebselen researchers used. But Kozikowski says funding for the project dried up and his group hasn’t worked on GSK-3 inhibitors for years.

Scolnick says his group at the Stanley Center has come up with some selective GSK-3 inhibitors, but he declined to comment on their structures. Now, he says, they’re doing classical medicinal chemistry to boost the molecules’ pharmaceutical profiles.

Some people are concerned about using GSK-3 inhibitors, Klein says. Inhibiting GSK-3 potently activates the Wnt pathway, he says, and activation of the Wnt pathway is a key step in roughly 90% of colorectal carcinoma. “The worry is that you’re going to cause cancer,” he says. “In the many years that lithium has been studied, there has been no increased incidence of leukemia or cancers in people taking lithium,” Klein is quick to add, “but a more potent GSK-3 inhibitor could be oncogenic.”

One drug that’s recently grabbed the spotlight for treating bipolar depression is the anesthetic agent ketamine. In the past few years, trials in people have shown that a subanesthetic infusion of the drug can relieve the symptoms of depression and suicidal urges in a matter of hours, says NIMH’s Zarate, who conducted some of the studies. The effect lasts about a week, whereas commonly prescribed antidepressants usually take weeks to work.

Ketamine is a derivative of phencyclidine, or PCP, and acts as an antagonist of N-methyl-d-aspartate glutamate receptors. There’s some evidence that its antidepressant effects may be modulated by GSK-3, although scientists aren’t sure how.

“It’s really ignited interest in drug discovery and development,” Zarate says. His group and others are looking into compounds that act like ketamine but last longer and don’t have ketamine’s psychotropic side effects.

Although interest may be picking up, efforts from the pharmaceutical industry to develop new drugs specifically to treat bipolar disorder remain rare. Last year PhRMA, the Pharmaceutical Research & Manufacturers of America, put out a report on medicines in clinical trials to treat mental illness. Most of the 12 compounds listed for bipolar disorder fall into the category of anticonvulsant or antipsychotic. Even the few that don’t fit into those categories were originally developed for other uses.

New drugs come at a price, though. “The expense of our medication is a problem,” says Leah Nakamura, who has bipolar disorder type I and coordinates several support groups for people with the illness. She points out that having bipolar disorder can make it tough to keep a job, so people lose their health insurance and can’t afford their medication.

Although lithium costs less than a dollar a day, drugs still under patent protection, such as aripiprazole (Abilify), can cost hundreds of dollars each month. “At some point you just can’t afford it,” Nakamura says, “and these are lifesaving drugs.”

Nakamura wishes she had better medications to choose from. She’s currently on her fifth drug to keep her bipolar symptoms at bay. If this one doesn’t work, she says, she doesn’t have many options, but she is still hopeful for the future. Nakamura says, “I tell our young adult support group, ‘Hang in there. Hope is on the way. They’re working on treatments for us.’ ”

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Posted in Uncategorized | No Comments »

“The Incarceration Revolution” : The Abandonment of the Seriously Mentally Ill to Our Jails and Prisons

Posted by admin2 on 23rd October 2012

By Joseph D. Bloom, MD – Dean Emeritus at the School of Medicine and a Professor Emeritus in the Department of Psychiatry at Oregon Health and Science University.
From - Conundrums and Controversies in Mental Health and Illness • Winter 2010

In 1848 Dorothea Dix, the famous 19th century advocate for the indigent mentally ill, appealed to the United States Congress to support the set- aside of a very large tract of land that was to be used for the “Relief and Support of the Indigent Curable and Incurable Insane.” She stated:

It will be said by a few, perhaps that each State should establish and sustain its own institutions; that it is not obligatory upon the general government to legislate for maintenance of State charities…. But may it not be demonstrated as the soundest policy of the federal government to assist in the accomplishment of great moral obligations, by diminishing and arresting wide-spread miseries which mar the face of society; and weaken the strength of communities?

The proposed legislation, the “12,225,000 Acre Act,” did pass the Congress, but was vetoed by President Franklin Pierce, who stated in his 1854 veto statement:

I have been compelled…to overcome the reluctance with which I dissent from the conclusions of the two Houses of Congress…. If Congress has power to make provision for the indigent insane…the whole field of public beneficence is thrown open to the care and culture of the Federal Government.

I readily…acknowledge the duty incumbent on us all…to provide for those who, in the mysterious order of Providence, are subject to want and to disease of body or mind but I cannot find any authority in the Constitution that makes the Federal Government the great almoner of public charity throughout the United States. To do so would, in my judgement, be contrary to the letter and spirit of the Constitution…and be prejudicial rather than beneficial to the noble office of charity.2

For most of our country’s history, the federal government followed the position taken by President Pierce and avoided major responsibility for the public mental health system or for that matter, now, for a national health system. In fact, the only time the federal government assumed a significant role in the care of the mentally ill was between the end of World War II and the election of Ronald Reagan in 1980. This era began with great optimism and ended with all the seeds of the current crisis in mental health care clearly apparent as the forces that were unleashed began to unfold.

Shown above is the exercise yard at the Oregon State Insane Asylum in about 1905. (Photo no. OSH0023, Oregon State Hospital Records, OSA)

Shown above is the exercise yard at the Oregon State Insane Asylum in about 1905. (Photo no. OSH0023, Oregon State Hospital Records, OSA)

Prior to and after the election of President Reagan, the states had the major responsibility for the care of the seriously and chronically mentally ill. The earlier state era was characterized by the large state mental hospital, while the current state era is characterized by the criminalization of the mentally ill. In order to describe the current condition, I will use the public mental health system in the State of Oregon as a case study. Oregon is chosen because of my 30-year experience with the public mental health system in this particular state. I believe and hope to illustrate that Oregon’s problems in the delivery of public mental health services are very similar to those that exist in most states.

The Federal Era in Mental Health Services

The linchpin of the federal era was John F. Kennedy’s 1963 Presidential Message on Mental Illness and Mental Retardation. President Kennedy described the failures of the past and looked forward to a new direction for the country. He stated:

Most importantly the institutions that housed such large numbers of mentally ill individuals were slated to be closed. Hospitalization, if needed, was to take place either in the community mental health center’s inpatient service or in the developing psychiatric inpatient services in local community general hospitals.

Unfortunately, in retrospect, and for a variety of reasons, the community mental health center movement was a conceptual success, but an actual failure. Not enough centers were funded. For those that were, the funding formula in the federal legislation was based on a decreasing federal match with state funds, and many states did not pick up the costs. In addition, the centers themselves were accused of not focusing sufficient resources toward the problems of the chronically mentally ill.

President Jimmy Carter attempted to refocus the federal program on the problems of the chronically mentally ill. He came to the presidency with a strong commitment to mental health services which he and President Kennedy’s concern was translated into a bill that was introduced into Congress one month before his death,4 enacted soon after, and signed by President Johnson. The passage of this legislation created the community mental health center movement.

I began my psychiatric residency in that same year, 1963, and experienced the community mental health center movement on a personal level. The movement was conceptually elegant. Each state was governed by a mandatory state mental health plan that divided the state into designated catchment areas. Each area was assigned a priority score for the development of a community mental health center responsible for the mental health care for the catchment area population. It was anticipated that catchment areas might differ as to the characteristics of their distinct populations. Using the developing methods of psychiatric epidemiology, the goal was to measure the amount and types of mental illness in the particular population and then tailor services to the particular needs of that population.

Each mental health center was to have inpatient, outpatient and partial hospitalization services, a 24-hour walk-in service for immediate care, along with a branch of consultation and education designed to strengthen the mental health fabric of the community.  Local administrative control and accountability were part of the CMHC governance and, of course, there was the promise of adequate funding.

Most importantly the institutions that housed such large numbers of mentally ill individuals were slated to be closed. Hospitalization, if needed, was to take place either in the community mental health center’s inpatient service or in the developing psychiatric inpatient services in local community general hospitals.

Unfortunately, in retrospect, and for a variety of reasons, the community mental health center movement was a conceptual success, but an actual failure. Not enough centers were funded. For those that were, the funding formula in the federal legislation was based on a decreasing federal match with state funds, and many states did not pick up the costs. In addition, the centers themselves were accused of not focusing sufficient resources toward the problems of the chronically mentally ill.

President Jimmy Carter attempted to refocus the federal program on the problems of the chronically mentally ill. He came to the presidency with a strong commitment to mental health services which he and his wife helped to strengthen in the State of Georgia.

As president, in 1979, he delivered a message on mental health which:

….establishes a new partnership between the federal government and the states in the planning and provision of mental health services. It seeks to assure that the chronically mentally ill no longer face the cruel alternative of unnecessary institutionalization or inadequate care in the community.5

In his message President Carter noted that although 700 community mental health centers had been built, serving some 3 million patients annually, the majority of the country’s population were not served by federally funded community mental health centers. During the same time period what actually did occur was the accelerated discharge of the state hospital patients into local communities. This came about for many reasons including the advances made in psychiatric drug treatment, and the great pressure coming from the legal and patient rights community driven in part by reforms in civil commitment laws.6 The results, as is evident, from President Carter’s words, were large numbers of chronically mentally ill individuals in the community, many who were faced with inadequate community level care.

To put President Carter’s words in perspective, in 1955 there were 558,239 state and county psychiatric beds in the United States.7 When he took office in 1976 there were 222,202 beds in the country, and when he left office in 1980 there were 156,713 beds.8 (For reference later in this paper, in 2005 there were 52,539 beds in what was left of state and county hospitals for the mentally ill.9) This was the time that the terms “deinstitutionalization,”10 “the homeless mentally ill,”11 and “the chronic mental patient in the community” first appeared in the mental health literature,12 and we first began to be concerned with the mentally ill as they became a significant population within the nation’s jails and prisons.13

The federal era ended with the election of President Reagan. He ended support for federally funded community mental health centers and instead funded block grants to the states to be used within general guidelines to support state services. However, it is important to note that since that time federal support of mental health programs has remained in the form of financial support to individuals and states through the Medicare and Medicaid programs. In essence federal leadership and national policy were replaced by financial support for individuals.

The New State Era in Mental Health Services: Oregon — A Case Example

Is the public mental health system in Oregon representative of the services provided in other states?

There are several studies that compare states on various indices related to mental health care. In 2006 the National Alliance for the Mentally Ill (NAMI) compared state mental health systems using a detailed quality index that rated programs along ten defined criteria14 ranging from comprehensive services and support, to access to acute and long-term care treat- ment, to adequate funding. These criteria were adopted to support recovery oriented treatment models which most public mental health programs support today.15

Five states received a grade of B with the highest scoring states being Connecticut and Ohio. Seventeen states received a C, 19 a D, and 8 were awarded an F. Oregon received a C+, while South Carolina received a B-. NAMI identified that the most urgent need in both of these states was “funding.” South Carolina was ranked 32nd in per capita funding for mental health while Oregon ranked 40th. NAMI gave the country as a whole a national grade of D.

In 2008, the Treatment Advocacy Center issued an online report that evaluated the adequacy of the number of state and county hospital beds in each state using a scale developed by an expert panel organized by the survey’s authors.16 In 2005, there were 17 public hospital beds per 100,000 in the U.S. population. The expert panel determined that 50 beds per 100,000 was the minimum number needed to provide adequate service. Eleven states, including South Carolina (10.6 beds per 100,000) were determined to have a “critical bed shortage” in public beds, while Oregon was listed with 20 other states as one category better in the “severe bed shortage” range, with 19.2 beds per 100,000. Only one state, Mississippi, at 49.7 beds per 100,000 was at the minimum number determined by the expert panel. From these two surveys at least, Oregon does not appear to be an outlier.

Oregon’s Programs

As in most states Oregon traditionally funded its state hospitals with general fund dollars while community funding is based on a “state-county partnership” written into law in 1973. Community programs are administered at the local level by county health and/or mental health departments.

This partnership was altered in the decade between 1993-2003 when the Oregon Health Plan was most prominent. Since 2003 the Oregon Health Plan (OHP) has been in decline,17 but some of the mechanisms that were set in place for the OHP, which included the establishment of specific insurance products and some mental health carve outs, remain in place.

Oregon’s State Hospitals

My colleagues and I recently examined the inpatient bed situation in Oregon in both state and private hospitals18 and found that for the most part Oregon’s psychiatric hospitals are full to capacity. In addition, the state is, in essence, running a forensic inpatient system for those who enter the hospital under the state’s civil commitment or criminal justice standards, those who are incompetent to stand trial, and those who enter under the jurisdiction of the Psychiatric Security Review Board.19 We found in another study20 that over the past 20 years civil emergency holds have increased as the population of the state has increased, while actual civil commitments have diminished by 50 percent. The state hospitals now predominantly serve the civil commitment court (24% of the state hospital population) and the criminal courts (63% of the state hospital population). The state hospitals contribute minimally to the general welfare of the non-court adjudicated Oregonian. In the same study (cited above) we found that over the last decade the number of general hospital psychiatric beds had significantly decreased in Oregon, and this decrease mirrors the national situation. It is extremely important to note that there is, in essence, no room for the voluntary patient in either state or the community hospital beds.

In addition to the issues related to those who are served at the state hospitals, Oregon’s major state hospital, the Oregon State Hospital (OSH), is operating under very heavy strain. Oregon is one of the oldest western states and OSH is one of the oldest state hospitals in the west. It was originally built in 1883 and most of its “newer” buildings are close to 50 years old. To understand the current pressures affecting OSH, it is helpful to understand three recent lawsuits and one threatened lawsuit.

The first suit,21 heard in the Federal District Court for the District of Oregon22 and decided in favor of the plaintiffs in 2002, sought to compel the State of Oregon to provide more expeditious treatment for criminal defendants who had been found incompetent to stand trial and who were languishing in Oregon jails waiting for beds at the Oregon State Hospital. The plaintiffs, presented data that showed that seriously mentally ill individuals were held in jails under very poor circumstances, for abnormally long periods of time, awaiting evaluation or treatment beds at the state hospital. Data was presented on 105 individuals who had been found incompetent to stand trial of criminal charges. These individuals spent an average of 32 days in jail waiting for a bed. Forty-eight were held for more than 30 days and nine were held for more than 60 days. Only 19 were transported to the hospital in fewer than seven days. The judge’s final order stated that admissions to the state hospital “must be done in a timely manner, and completed not later than seven days after the issuance of an order determining a criminal defendant to be unfit to proceed to trial because of mental incapacities.”

The second law suit, settled in 2003, was a class action suit23 brought against Oregon’s two state hospitals, contending that the defendants failed “to develop the array of community-based mental health services needed to meet the special needs of a group of patients, causing them to remain unnecessarily institutionalized in Oregon state hospitals.” This case was Oregon’s response to the 1999 United States Supreme Court decision in Olmstead v. L.C.24 in which the Court held that states were required to provide community based treatment when treatment professionals had determined that these placements were justified. The Oregon case was concluded with a settlement agreement which applied to “civilly committed adults in Oregon state hospitals” and “who had not been discharged within 90 days of the ready-to-place determination of their Treatment Team.” The state agreed to develop additional community based facilities and resources to accommodate members of the class.

The third law suit, Harmon v. Fickle,25 finalized in 2006, alleged that the State failed to provide adequate numbers of professional and direct care staff at the state hospital; failed to provide adequate and “meaningful” treatment; had violated multiple plaintiffs’ rights to privacy; and failed to protect patients from harm. The settlement agreement stated that the state would take “all necessary steps within their control” to increase the staff patient ratio by both hiring more staff and by reducing the state hospital population by developing secure residential treatment options in the community. The state legislature made funds available to achieve these goals, but to date neither goal has been reached. The hospital has been unable to hire sufficient staff, mainly nursing and psychiatric staff, and attempts to contract for more community secure residential placements especially for those hospitalized from the criminal courts have met severe resistance in several of Oregon’s communities.

These problems at the Oregon State Hospital led to a 2006 Department of Justice investigation under the authority of the Civil Rights of Institutionalized Persons Act (CRIPA).26 In January of 2008 the Justice Department issued its findings, a stinging critique of the hospital.27 The CRIPA investigators found that the hospital failed to protect patients from patient to patient assault, and from the physical dangers inherent in the aged facilities themselves. There was a heavy emphasis in the report on the problem of inadequate nursing care. In addition the report faulted aspects of psychiatric and psychological practices including lack of adequate assessments, medication management, and overuse of seclusion and restraint, with additional weakness found in discharge planning.

The 2007 Oregon Legislature responded to the CRIPA investigation with a significant financial commitment to build two new state hospitals with a total of 1100 beds. The numbers of professional staff needed for these hospitals was not actively debated,and the need is only now beginning to become apparent to state leaders within the executive and legislative branches. The question of how to find the requisite numbers of nurses and physicians is yet to be addressed along with the sticker shock that will no doubt accompany this discussion.

Oregon’s Community Mental Health Programs

The situation is not much better with regard to Oregon’s community mental health programs. These programs serve predominantly three categories of clients: those who remain as OHP beneficiaries, those who receive traditional Medicare and Medicaid benefits, and those with no coverage of any sort (the medically indigent). There is limited funding with limited treatment options available for the medically indigent.

Cascadia Behavioral Health, a not-for-profit private agency, operated on contracts with state and local governments and on fee-for-service revenue. The program provided mental health services to 20,000 clients in five of Oregon’s largest counties, particularly in Portland, the state’s largest city, and at its height had a budget of some $60 million per year.

The Cascadia story provides an instructive lesson in regard to the problems inherent in community mental health programs in this state. What it says is that these programs operate very close to the margin. In essence, they are grossly under-funded by both state and county governments. If they are not extremely well managed, they will run into trouble, as was the case with Cascadia Behavioral Health. State and county officials responsible for oversight were not sufficiently aware of the problems because too little attention was paid to program evaluation and oversight.

Consequences

President Carter stated in 1979 that “unnecessary institutionalization” has given way to “inadequate community care.” He was correct, and in retrospect the dynamics were clear, resulting from the rapid reduction in the number of inpatients; closure of beds; increased vigilance, legal and otherwise, at the front door blocking easy access to the remaining beds; decreasing federal responsibility for the community mental health center movement; and the inability or unwillingness of states to assume the necessary financial burden to adequately fund hospital and community programs. All of these factors have produced the current situation with the most negative result being the large-scale criminalization of the mentally ill.

“Unnecessary institutionalization” has been replaced in many places by unavailable institutionalization. This situation is highlighted by the Oregon data, and nationally by the Treatment Advocacy Center,28 the National Association of State Mental Health Program Directors,29 the American Medical Association and the American College of Emergency Physicians,30 President George W. Bush’s New Freedom Commission,31 and a recent commentary in the American Journal of Psychiatry.32

This situation in Oregon and across the U.S. leads to an inevitable pathway to the nation’s jails and the prisons.33 In a recent commentary in the Journal of the American Medical Association, H. Richard Lamb and Linda Weinberger,34 citing evidence from the National Commission on Correctional Health Care, reported that in 2006 there were “at least” 341,000 incarcerated persons with severe mental illness in the United States, representing approximately 15% of incarcerated individuals in that year.

Bernard Harcourt contributed an added dimension to the discussion of mental hospital institutionalization in the United States by analyzing aggregate data from mental hospitals and jails and prisons in the years 1928-2000.35 He noted that hospitalization rates peaked in 1955 and declined rapidly after that date reaching the low levels cited in this paper (deinstitutionalization) and also noted that since the early 1980s the country is in an expanding period of criminal incarceration (the “incarceration revolution”). By combining data from both mental hospitals and the jails and prisons, Harcourt found that the current combined level of institutionalization had not yet reached the aggregate levels that existed in 1955. He also noted an inverse relationship between decreasing total institutionalization and the national homicide rate. Harcourt argues for further investigation to look for precise explanation for this finding.36

From the criminal justice system perspective, the current era is characterized as an “incarceration revolution,” while from the mental health perspective the era of deinstitutionalization has given way to the era of the criminalization of the mentally ill. The public mental hospitals now have the lowest number of beds in decades, and over the last decade we have been losing community hospitals beds, even as our population continues to increase.37

Are There Any Solutions?

Here it is appropriate to briefly discuss the question of national policy and the political process. First and foremost, there needs to be a national mental health plan, a consensus plan that is actively supported by the federal government.

We haven’t had clear national mental health policy since the administrations of Presidents Kennedy, Johnson, and Carter. There was some hope of positive movement early in the presidency of George W. Bush when in 2002 he appointed the New Freedom Commission on Mental Health charged with studying the mental health service system and making recommendations for improvements in the system.38 The president set out five Principles to guide the Commission, one of which, however, stated that:

The Commission shall follow the principles of Federalism, and ensure that its recommendations promote innovation, flexibility, and accountability at all levels of government and respect the constitutional role of the States and Indian tribes.

Reminiscent of President Pierce, this statement meant that President Bush was not interested in the development of national policy that would govern approaches in each state. That said, the Commission did make a serious effort to comprehensively describe the state of the country’s mental health service system, including its current deficits, and developed six goals for improving the system. The Commission also recognized the work of promising programs from various parts of the county. But, in keeping with the spirit of the new federalism, little comprehensive federal policy changes were recommended and little attempt was made that would bind the country to another major and unified approach that would address the current problems and look to a better future.

In addition, at the political level, recent decades of American politics have fueled the incarceration revolution. In many areas of political life, politicians have used fear and sensationalism as pathways to election.

Data is certainly not king in the public arenas. Incarceration is far cheaper when compared to mental hospitalization, and in every political race in this country the pledge of “no new taxes” has become an effective route to electoral success. And further, the police, courts, and jails and prisons remain the last resort, governed by laws which make it very difficult to pass the buck, as states have done in mental health care. The buck stops inside the doors of the jails and prisons. A rational conclusion would be that we probably do not have the political will to move into a new era of revitalization of the public mental health programs. If, however, there was a chance to move away from the “incarceration revolution” and attempt to rebuild the public mental health programs, we would be wise to look to the past for some guidance as there were many excellent program models that were developed that might serve as guides to future systems.

We have already noted the innovative program models embodied in the federally funded Community Mental Health Center (CMHC) of the 1960s and 1970s, which were based on the principles of public health psychiatry.39 In addition, there certainly is a need for a concerted effort to rebuild and expand psychiatric inpatient capacity. This is not a call for the reconstruction of the total institutions of the past, but for an adequate number of psychiatric beds in our communities to provide the necessary inpatient evaluation, treatment, and stabilization services that form the backbone of modern acute psychiatric services. Additionally, communities need an adequate number of public sector beds in acute care facilities to provide the necessary backup to criminal justice system detainees with severe mental illnesses. In 1960, Portia Bell Hume and Edward Rudin40 described the funding received by the state of California’s mental health program from the federal government via the Hill Burton Act and from the state’s Short Doyle Act. Both of these well-known laws were designed to encourage the development of general hospital psychiatric units. We are greatly in need of similar commitments now at both the state and federal levels.41

Included with the need for a revitalization of inpatient mental health services is the re-development of functional civil commitment laws. In years past civil commitment was the diversion method of choice for removing individuals from the criminal justice system and transferring them to the mental health system. Civil commitment provided hospitalization for individuals suffering severe psychiatric decompensation, before their behaviors brought them into contact with the criminal justice system. For those already in the criminal justice system and charged with minor crimes, civil commitment provided the major route for diversion into the mental health system. A constructive alternative to current civil commitment laws was developed by the American Psychiatric Association in the early 1980s. This model statute was never implemented among the states,42 but it is time to review it again as it contained many forward-thinking approaches to civil commitment.

It is important to note that currently, and only in a few communities, mentally ill individuals charged with crimes may be diverted from jail by the developing system of mental health courts.43 These methods, although promising and somewhat effective, do not take mentally ill persons out of the criminal justice system, thus leaving them vulnerable to the heightened stigma associated with such involvement.

In closing, although this article has focused a great deal of attention on inpatient care, it is important to conclude by acknowledging that it is the outpatient, residential, and occupational components of a mental health program that really comprise the core of services. All inpatient treatment are only in the service of a rapid reintegration of individuals into their communities, and into as productive situations as they are capable of achieving. Great strides have been made in these areas, but these advances cannot be realized without adequate support. Perhaps this will ultimately come from national mental health parity legislation. Perhaps adequate or even excellent out- patient care will come ultimately from a functional national health insurance program, or perhaps from a separate national mental health policy, but it must come as the central focus of a comprehensive mental health program if the national mental health plan is to be successful.

Note

This article was presented at the Fifteenth Annual Thomas A. Pitts Memorial Lectureship in Medical Ethics, Medical University of South Carolina, Charleston, SC.

References

1.    B. E. Harcourt, “From the Asylum to the Prison: Rethinking the Incarceration Revolution,” Texas Law Review 84 (2006): 1751-1786.
2.   H.  A. Foley and S. S. Sharfstein, Madness and Government: Who Cares for the Mentally Ill (Washington, D.C.: American Psychiatric Press, 1983).
3.    J. F. Kennedy, “Message From the President of the United States Relative to Mental Illness and Mental Retardation,” The White House, February 5, 1963.
4.    Public Law 88-164, 88th Congress, S. 1576, October 31, 1963.
5.    J. Carter, “Message from the President of the United States Transmitting Legislation to Improve the Provision of Mental Health Services…Throughout the United States” (Washington, D.C., U.S. Government Printing Office, 39-011-0, 1979).
6.   A.  A. Stone, Mental Health and Law: A System in Transition (Rockville: NIMH, 1975).
7.    See Carter, supra note 5.
8.   E.  F. Torrey, K. Entsminger, J. Geller, J. Stanley, and D. J. Jaffe, “The Shortage of Public Hospital Beds for Mentally Ill Persons,” available at <http://www.treatmentadvocacycenter.org/Reportbedshortage.htm> (last visited September 6, 2010).
9.    Id.
10.   E.  L. Bassuk and S. Gerson, “Deinstitutionalization and Mental Health Services,” Scientific American 238, no. 2 (1978): 46-53.
11.   H.  R. Lamb, ed., The Homeless Mentally Ill: A Task Force Report of the American Psychiatric Association (Washington, D.C.: American Psychiatric Association, 1984).
12.   J.  A. Talbott, ed., The Chronic Mental Patient: Problems, Solutions, and Recommendations for a Public Policy (Washington, D.C.: American Psychiatric Association, 1978).
13.   J.  D. Bloom, L. Faulkner, J. H. Shore, and J. L. Rogers, “The Young Adult Chronic Patient and the Legal System: A Systems Analysis,” New Directions for Mental Health Services 19 (1983):37-50.
14.    NAMI, “Grading the States, A Report on America’s Health Care System for a Quality Mental Health System: A Vision of Recovery,” available at <http://www.nami.org/Content/NavigationMenu/Grading_the_States/> (last visited April 30, 2006).
15.   W.  A. Anthony, “A Recovery-Oriented Service System: Setting Some System Level Standards,” Psychiatric Rehabilitation Journal 24 (2000): 159-168.
16.    See Torrey et al., supra note 8.
17.    J. Oberlander, “Heath Reform Interrupted: The Unraveling of the Oregon Health Plan,” Health Affairs 26, no. 2 (2007): 96-105.
18.    J. D. Bloom, B. K. Krishnan, and C. Lockey, “The Majority of Inpatient Psychiatric Bed Should Not Be Appropriated by the Forensic System,” Journal of the American Academy of Psychiatry and the Law 36, no. 4 (2008): 438-442.
19.   J. D. Bloom and M. H. Williams, Management and Treatment of Insanity Acquittees, A Model for the 1990s (Washington, D.C.: American Psychiatric Press, 1994).
20.     J. D. Bloom, “Civil Commitment is Disappearing in Oregon,” Journal American Academy of Psychiatry and Law 34, no. 4 (2006): 534-537.
21.    OAC, et al. v. Mink et al: Findings of Fact and Conclusions of Law, U.S. District Court for the District of Oregon, Case No. 02-003-00339-PA, May 9, 2002.
22.     Miranda et al v. Kulongoski, et al., Settlement Agreement, United District Court for the District of Oregon, Case No. CV00-1753- HU, December 18, 2003.
23.     Id.
24.     Olmstead v. L.C., 527 U.S. 581, 1999
25.    Harmon v. Fickle, Settlement Agreement, Case No. 05-1855-BR, United States District Court for the District of Oregon, April 17, 2006.
26.     Civil Rights of Institutionalized Persons Act (CRIPA), 42 U.S.C.C$ 1997.
27.    Report, CRIPA Investigation of the Oregon State Hospital, available at <http://www.oregon.gov/DHS/mentalhealth/osh/cripa06review/2-cripa-report.pdf> (last visited September 19, 2010).
28.     See Torrey, supra note 8.
29.    National Association of State Mental Health Program Directors, “The Crisis in Acute Psychiatric Care,” Report of a Focus Group Meeting, National Association of State Mental Health Program Directors, Washington, D.C., 2006.
30.     American Medical Association House of Delegates, American College of Emergency Physicians, Resolution 714 and 716, 2007.
31.    Subcommittee on Acute Care, Background Paper, New Free-
dom Commission, (Washington, D.C., DHHS Publication No.
SMA-04-3876, 2004).
32.    B . Liptzin, G. L. Gottlieb, and P. Summergrad, “The Future of Psychiatric Services in General Hospitals,” American Journal of Psychiatry 33, 10 (2007): 1498-1472.
33.     H. R. Lamb and L. E. Weinberger, “The Shift of Psychiatric Inpatient Care From Hospitals to Jails and Prisons,” Journal of the American Academy of Psychiatry and Law 33, no. 4 (2005): 529-534.
34.     H. R. Lamb and L. E. Weinberger, “Mental Health Courts as a Way to Provide Treatment to Violent Persons With Severe Mental Illness,” JAMA 300, no. 6 (2008): 722-724.
35.    See Harcourt, supra note 1.
36.     d.I
37.    See Bloom and Williams, supra note 19.
38.    President’s New Freedom Commission on Mental Health, available at <http://www.mentalhealthcommission.gov> (last visited September 24, 2010).
39.   G  . Caplan, Principles of Preventive Psychiatry (New York: Basic Books, 1964).
40.   P . B. Hume and E. Rudin, “Psychiatric Inpatient Services in General Hospitals,” California Medicine 93 (1960): 200-207.
41.    See Liptzin, Gottlieb, and Summergrad, supra note 32; see Torey et al., supra note 8.
42.     American Psychiatric Association, “Guidelines for Legislation on the Psychiatric Hospitalization of Adults,” American Journal of Psychiatry 140, no. 5 (1983): 672-679.
43.   M  . N. Schaefer and J. D. Bloom, “The Use of the Insanity Defense as a Jail Diversion Mechanism for Mentally Ill Persons Charged With Misdemeanors,” Journal of the American Academy of Psychiatry and the Law 33, no. 1 (2005): 79-84; P. A. Griffin, H. J. Steadman, and J. D. Petrilla, “The Use of Criminal Charges and Sanctions in Mental Health Courts,” Psychiatric Services 53 (2002): 1285-1289.

Tags: , , , , , ,
Posted in Uncategorized | No Comments »

With deadline for agreement with DOJ stalled, police rush to make changes

Posted by admin2 on 17th October 2012

Chief Mike Reese says the PPB Crisis Intervention Team will be reconstituted. These changes are not what the DOJ specified in their Preliminary Agreement on Reforms Regarding Portland Police Bureau’s Use of Force Against Persons with Mental Illness.


We OPPOSE this change. From the launch of CIT in Portland until all officers were trained in response to the brutal death of James Chasse, families of persons with mental illness had to make due with the constant excuse, “We don’t have a CIT officer available.” Few if any of the police shootings of persons with mental illness in the last decade were situations where a specially trained officer could be brought to the scene. (Aaron Campbell is an exception, but he was identified by police as drunk and not mentally ill, so no mental health professional was consulted.)


The Portland Police Bureau’s earlier effort at satisfying the DOJ is a new ‘suicide’ crisis line, Lines for Life, duplicating and competing with an in-place, effective and paid-for system, the Multnomah County Crisis Line (503-988-4888). If there was any logic here, it escapes us. (MHAP, as usual, was not invited as a ‘stakeholder’).

PORTLAND POLICE BUREAU NEWS RELEASE
Chief Mike Reese Changes Policies, Creates Crisis Intervention Team in Response to DOJ Investigation

Portland Police Chief Mike Reese

Portland Police Chief Mike Reese

The Portland Police Bureau is making changes in response to the recent Department of Justice (DOJ) investigation. These changes are in regard to crisis response during encounters with someone with mental illness or perceived to have mental illness, as well as policies involving force.

Crisis Intervention Team

Recently, Chief Mike Reese met with members of the National Alliance on Mental Illness (NAMI), as well as other mental health stakeholders and families whose loved ones struggle with mental illness. The group discussed how officers respond to these situations, which are complex and unfold quickly. Arriving officers most often do not know if the person is suffering from a medical problem, mental health issue, drug and alcohol issues, or some combination of two or more. With that in mind, the Chief is creating a Crisis Intervention Team – a volunteer specialized team.

Under this new model, the Police Bureau will continue training all officers in CIT, but we will also have a team of officers, who receive enhanced training to ensure they have consistent updates related to resources and mental health and addictions systems issues. These officers will continue to work their normal patrol duties, but can dispatched to a call in progress where mental health issues are the primary reason for the call. If no crisis calls are waiting, CIT Officers will perform their regular duties. In addition, these officers will work in coordination with the Mobile Crisis Unit to identify individuals in our community who have frequent police contact due to their mental health and/or addiction issues.

The internal bureau position announcement was posted on Monday and will involve officers currently working a uniform assignment. They will be selected after November 15, 2012.

Changes to Directives

The Bureau is also making changes to three Directives that involve force: Taser, Application of Force and Use of Deadly Force.

The Bureau already has a higher standard than the federal standard when it comes to use of force. But the Bureau aspires to continual improvement: These draft Directives are in response to the DOJ, but also contain changes that bring the Bureau in line with its current training as well as best practices in policing.

The Bureau is asking the community for feedback on all three draft Directives. After reading the directive, there is a place for community members to provide comments.

READ the PPB directives (PDFs of Word documents with Track Changes amendments – http://www.portlandonline.com/police/index.cfm?c=59757
READ – PPB Manual of Policy and Procedure

All comments are due by Friday, November 2, 2012. Send your comments via email to Mike Reese because this FORM is ridiculous.


READ – Portland police chief to bring back specialized Crisis Intervention Team to handle mental health crisis calls, Oregonian, October 17, 2012
READ – Portland Police chief’s draft policy changes on use of force embrace some DOJ reforms, not others, Oregonian, October 17, 2012
READ – Police Bureau announces policy changes after DOJ report, KATU.com, October 17, 2012
READ – DOJ Fallout: Cops Restore Mental Health Unit, Tighten Taser, Deadly Force Policies, Portland Mercury, October 17, 2012
READ – Portland Police Bureau policy, 1051.00 TASER, LESS LETHAL WEAPON SYSTEM
READ – Portland Police Bureau policy, 1010.00 APPLICATION OF FORCE
READ – Portland Police Bureau policy, 1010.10 DEADLY PHYSICAL FORCE

Tags: , , , , , , , , ,
Posted in Uncategorized | 1 Comment »

Is the Oregon State Hospital No Longer Mired in Misery?

Posted by admin2 on 18th March 2012

Salem Statesman Journal, March 18, 2012

Stava Rikai, a patient in the transition program, talks with Sara Slack, a board certified art therapist, outside an art therapy room at the Oregon State Hospital in Salem, March 15, 2012. (Danielle Peterson | Statesman Journal)View Full Size   (Danielle Peterson | Statesman Journal)

Stava Rikai, a patient in the transition program, talks with Sara Slack, a board certified art therapist, outside an art therapy room at the Oregon State Hospital in Salem, March 15, 2012.

For decades, the Oregon State Hospital was mired in misery.

Behind the Salem hospital’s crumbling facade, mentally ill Oregonians were packed into a bleak, antiquated and unsafe asylum.

New state-of-the-art facilities are now in place, but opinions are divided when it comes to a key question: Are patients receiving better treatment in the new hospital?

Doubts are expressed by some patients.

“I don’t know if the treatment we’re getting is that much better, but it is definitely a nicer place,” said patient Renee Putnam, 31.

Patient Stava Rikai said he is reserving judgment on the quality of care delivered in the new facility. But he said the push for improved treatment has gained momentum in recent years with the creation of treatment malls, where patients gather during the day for therapy.

Development of the treatment malls ended the outdated practice of keeping patients cooped up on crowded treatment wards for therapy.

Therapists and mental health activists describe the treatment malls as a significant reform.

Maggie Bennington-Davis, a psychiatrist who runs Cascadia Behavioral Healthcare, a non-profit agency that provides community-based services for people with mental illness, sees signs that patients coming out of the hospital after stints of treatment are better prepared to resume their lives.

Details

The basics: The new $280 million, 620-bed Oregon State Hospital is the first of two new hospitals planned to replace the former OSH complex, which was deemed obsolete and unsafe by state-hired consultants in 2005. Plans call for the second hospital to be built on state prison land in Junction City.

What’s new: This week, about 180 patients moved in to the final wing of the new hospital, which is now fully occupied and operational.

The costs: Budgeted costs for building the two hospitals total $458 million.

“It seems like people are readier, further down the road, in terms of thinking about their own recovery and being engaged in treatment,” she said. “So I think the treatment within the walls is probably improving. Certainly a new facility helps along those lines, especially when you’re moving out of a pretty awful old facility.”

As many people tell it, Greg Roberts, superintendent of the hospital since September 2010, has played a key role in turning around the hospital.

“Greg Roberts is persistent,” said psychologist Daniel Smith, who has worked at the hospital for eight years. “He is working with both unions here at the hospital and with the management staff to bring about change. In 18 months, he has brought more change than occurred here for quite some time.”

During Roberts’ tenure, the hospital has slashed the number of internal committees, filled long-vacant administrative posts, streamlined how patient privileges are determined and given patients more say about their own treatment.

Roberts also has pledged to reduce and eventually eliminate mandatory overtime, a promise that appeals to staffers who long have complained about mandated double shifts.

The hospital chief also has won over mental health activists who describe him as a skilled catalyst for positive change.

“He doesn’t accept pat answers, and he’s got some real social skills in terms of leadership that I haven’t seen in a superintendent previously,” said Beckie Child, executive director at Mental Health America of Oregon.

Unlike past hospital leaders, Roberts is no stranger to patients and staffers on the front lines of care, Child said.

“Greg is out walking the wards,” she said. “He comes at odd hours to see what’s happening at the hospital. That thrills me.”

History of Neglect

State leaders long turned a blind eye to institutional decay. They also neglected the human anguish that piled up like dirty laundry at the same hospital where “One Flew Over the Cuckoo’s Nest” was filmed in the 1970s.

Now, though, many people say the 129-year-old psychiatric facility is on the upswing.

“I think the most outstanding thing is that we’ve done away with the old Cuckoo’s Nest and replaced it with something that is more beneficial and more humane,” Rikai said.

Rikai, 29, moved into the new hospital this week, along with about 180 fellow patients. They made up the last wave of patients to exit old hospital units and settle into the new 620-bed facility.

For Rikai, preparing for the switch revived memories of the former hospital’s prison-like look and feel.

“It was just very oppressive,” he said. “There is no way that razor wire can be humane.”

Living conditions in the new hospital provide patients with more privacy and dignity, Rikai said.

Staffers agree.

Joe Thurman, a nurse who has worked at the state hospital for 15 years, described the new facility as “a godsend.”

“I’m glad they have it done,” he said. “I think our patients deserved better than (conditions at) the prisons, and we do have some good programs.”

Smith, the psychologist who has worked at the hospital for eight years, said staff morale has rallied amid the shift to modern facilities and a push to provide each patient with individualized therapy.

“As would happen with any facility, there’s some growing pains as we find out that there are some flaws,” he said. “Overall, it’s a tremendous benefit. We are better able to provide services. The environment itself is physically safer.”

With full occupancy of the 870,000-square-foot complex, Smith envisions the psychiatric hospital entering a progressive new era.

“We have, in general, more resident freedom on the grounds than at any other time in the history of the hospital,” he said. “We have more opportunities for community integration. And we are moving more toward a recovery model. And staff are embracing that model as they see it be successful.”

Talk of a turnaround at OSH is noteworthy, in part, because of its long-troubled history. Until recent years, state leaders ignored a litany of hospital problems, including severe under-staffing, high rates of patient-caused violence, security breakdowns and dangerous conditions in run-down buildings.

A multitude of flaws and failings were spotlighted in January 2008, when the U.S. Department of Justice issued a blistering report that criticized nearly every facet of patient care and hospital conditions.

Federal investigators urged the state to make sweeping improvements or risk being hit with a civil rights lawsuit that could put the institution under federal court control.

The harsh federal critique prompted state officials and legislators to allocate extra money for additional staffing and speed up other improvements.

Construction of the new hospital was green-lighted by legislators before the damning federal report. The building came on line in phased fashion, culminating in this month’s last round of patient moves into the completed facility.

Chris Bouneff, executive director of NAMI Oregon, short for the National Alliance on Mental Illness, expressed mixed emotions about the new facility.

“The Salem campus is not ideal,” he wrote in an e-mail to the Statesman Journal. “Congregate care for 620 people is never ideal. But without the reconstruction of the state hospital, providing any care would have remained impossible. You cannot heal when the physical environment is in shambles, nor can you provide proper care if your physical workplace is in such disrepair that it works against you.”


‘Like’ this Posting on Facebook

Tags: , , , , , , , , , , ,
Posted in Uncategorized | No Comments »

Mental Health Drugs To Come Under Review by Central Oregon Health Council

Posted by admin2 on 9th March 2012

By Amanda Waldroupe, for The Lund Report, March 1, 2012

These drugs will continue to be reimbursed by the Oregon Health Authority’s Department of Medical Assistance Programs but provide local officials with more information on the effectiveness of the medications

By July, the Oregon Health Authority is expected to begin providing real-time data to the Central Oregon Health Council, which coordinates the care of Oregon Health Plan patients in Deschutes, Crook and Jefferson counties, on the mental health drugs used by people living in that area.

Senate Bill 1506 passed the House and Senate unanimously earlier this week, directing the Oregon Health Authority to provide data on which mental health drugs are being used, how often patients fill their prescriptions, whether they fill them as prescribed and other information relating to patients’ use of the mental health drugs.

Elizabeth Steiner Hayward

Elizabeth Steiner Hayward

The Oregon Prescription Drug Program, which purchases mental health drugs for some state agencies, including the Oregon Health Authority, will be responsible for sharing the data with the Central Oregon Health Council, which is made up of representatives from various provider groups and county government.

The bill applies to all mental health drugs that are currently paid for directly by the Oregon Health Authority’s Department of Medical Assistance Programs, rather than the managed care plans throughout the state, in what’s known as the mental health “carve out.”

“It is the one piece of the healthcare puzzle that’s still paid for directly by the state,” said Sen. Elizabeth Steiner Hayward (D-Hillsboro).

Chris Bouneff, the executive director of Oregon’s chapter of the National Alliance of Mental Illness (NAMI), said this “carve out” was created to protect patients and ensure that they receive the most effective medication. Also, a patient’s access to these mental health drugs will never be interrupted – even if the costs exceed the budget – the state will continue paying the bill.

Finding the right medication for a person with a particular mental illness can be difficult, Bouneff said, because two people with the same mental illness can react differently to the same drug, and many drugs can take weeks or months to become effective.

“You want to be very careful about starting the person on the right medication,” Bouneff said. “Failure can be catastrophic when we’re talking about mental health drugs.”

But because the state pays directly for these drugs, a patient’s provider or their managed care plan may not know about the effectiveness of these medications until six weeks later. “That’s not helpful,” Bouneff said, particularly when providers are attempting to integrate physical and mental healthcare.

“[You] can’t achieve full coordination without seeing data about those drugs,” said Robin Henderson, acting executive director for the Central Oregon Health Council, which is made up of representatives from various Central Oregon provider groups and county government.

The bill’s supporters say the legislation, and the ability to review current data, will help physicians better coordinate the care of their patients. “Physicians need to have real time access to the data of what mental health drugs a person is taking,” said Rep. Val Hoyle (D-Portland). “It makes sense that if we’re going to integrate care that we also integrate access to information.”

Steiner Hayward believes the data sharing will be a “model for how the Oregon Health Authority can interact with [coordinated care organizations] moving forward.”

Coordinated Care Organizations, or CCOs, will create patient teams made up of doctors, nurses, behavioral health providers, community health workers, and other providers who will integrate physical, mental and dental healthcare for 600,000 patients on the Oregon Health Plan. The hope is that by focusing on preventive care and reducing emergency room utilization, costs can be reduced. With the passage of Senate Bill 1580 last week, the Oregon Health Authority is preparing to implement CCOs throughout the state starting July 1.

Senate Bill 1506 underwent a substantial amount of change from its original version. Originally, the bill would have created a two-year pilot program allowing PacificSource, the managed care plan in Central Oregon, to pay for the drugs themselves.

prescription drugs and bottles

PacificSource would have used a capitated rate for these drugs — setting aside a certain amount of money, and the health plan uses a capitated rate for its other health services. There was a provision in the original bill that said that if PacificSource exceeded the costs for the drugs, the state would have stepped in and paid the difference.

“It would change who the money was flowing through. It didn’t change access, and there was a backstop,” Bouneff said.

Allowing PacificSource to pay for the drugs, Bouneff said, would have allowed the managed care plan to analyze the cost of the drugs, as well as develop ways to improve a patient’s health so that they would be less dependent on the drugs — and thus save money.

“The thrust of the pilot was getting education out to prescribers, pharmacists and patients so people could make very informed choices,” Bouneff said. “And you had this integration of information so we could really focus on health outcomes. If you use medications strategically, a patient’s health outcomes improve and you can reduce the cost of the medications.”

But the bill received a substantial amount of opposition particularly among pharmaceutical groups, even though there was no testimony during the public hearings. Jim Gardner, a lobbyist for PhRMA, did not return a call for comment, but Bouneff said the pilot project could have affected pharmaceutical companies “free reign to influence prescribing.”

Tom Burns, the Oregon Health Authority’s director of drug purchasing, sent a letter to the Senate’s Healthcare committee saying that the Department of Medical Assistance Programs could develop a way to send data to the Central Oregon Health Council within 24 hours, instead of the typical six-week wait.

Bouneff said he and others doubt whether the Oregon Health Authority will actually be able to provide the data in a timely manner. “This is something we’ve asked the state to do, and they’ve shown no interesting in doing it.”

The Central Oregon Health Council also intends to establish a clinical advisory committee — something that was in the original bill, but not in the final version — that will look at ways to integrate information about mental health drugs, as well as how to better manage the medications, and improve a patient’s health. The council is expected to submit a report on this project during the 2013 legislative session.

Photos for this story appear courtesy of The Oregonian.


‘Like’ this Posting on Facebook

Tags: , , , , , , , , , , , , , ,
Posted in Uncategorized | No Comments »

Help People With A Mental Illness Help Each Other: Donate to Eyes & Ears

Posted by admin2 on 26th February 2012

Will Hall speaks about the fundraising campaign for the Eyes & Ears newsletter

Hello, my name is David Green, and I would like to talk to you about the Eyes & Ears Newsletter, which is created by consumers of mental health services to help their fellow consumers in their recovery, and also share valuable information with family members and professionals, who can in turn share it with the consumers in their lives.

The staff of Eyes & Ears are themselves consumers in the mental health system, who have been working with consumer newsletters for more than twenty years. I am the Assistant Editor, and work with Duane Haataja, our Editor.

We provide news, resources, and stories of hope and recovery. Your donation will help us help our fellow consumers, by putting resources, news, and hope into their hands – all of which will help them, and us, on our journey of recovery.

Our journeys are as individual as we are, and we provide information from a wide variety of viewpoints – from the mental health consumer/survivor movement and the traditional mental health system, from NAMI and Robert Whitaker, and our readers themselves, who are always welcome to make contributions.

We are already a valued resource for consumer/survivors, and are one of the most widely-distributed consumer/survivor publications on the internet. A limited number of paper copies are already being printed and distributed by Cascadia Behavioral Healthcare at their clinics.

We want to provide paper copies of our newsletter to the many consumers who can’t afford internet access. Poverty is a fact of life for many of us. Our newsletters will be distributed at local mental health clinics, residential complexes, and anywhere consumers could use some hope.

We are doing this fundraising campaign thru Kickstarter. Our campaign ends on March 2nd. Your donation will be matched by one of our donors, so it will go twice as far! As of the evening of Sunday, Feb. 26th, we have raised $1880 from 24 backers. We are trying to raise $4000. Use the following link to donate:

Eyes and Ears Fundraising Campaign on Kickstarter

A donation of any size will be appreciated, and will help provide news, resources, and hope to aid our fellow consumers in their journeys of recovery.

See the current issue of Eyes & Ears
See postings about, and past issues of, Eyes & Ears


‘Like’ this Posting on Facebook

Tags: , , , , , , ,
Posted in Uncategorized | No Comments »